PPD

JULY 13, 2023

At the beginning of 2023, the PPD clinical research business of Thermo Fisher Scientific surveyed 120 drug developers across the pharmaceutical, biopharmaceutical and biotechnology sectors (referred to collectively as “pharma”) to learn more about sponsors’ current needs for site and patient recruitment services.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52

H1 Blog

NOVEMBER 15, 2023

Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game. Compliance ensures that interactions between pharmaceutical companies and KOLs are transparent, fair, and free from any undue influence.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

The Pharma Data

NOVEMBER 20, 2020

Pharma leaders fear extreme vulnerability in end-to-end supply chain as pandemic continues, according to global survey. Explore how pharma companies and industry leaders can reset for growth in the lab beyond coronavirus in Pharma IQ ’s fourth annual edition of Smart Lab Digital. Download a copy of the report here.

Pharma Companies 52

Pharma Companies Vaccine Drugs Pharmacy 52

The Pharma Data

DECEMBER 11, 2020

Find out below how Thermo Fisher Scientific and the University of Oxford are working together to combat the Covid-19 pandemic and discover how pharmaceutical logistics companies are preparing for vaccine distribution. Thermo Fisher Scientific gains CE Mark Certification for its Covid-19 test.

Vaccine 52

Vaccine Immune Response Pharma Companies Virus 52

Advarra

JULY 19, 2022

The sponsor is the pharmaceutical company conducting the trial. For more information on key components of a fit-for-purpose, phase-by-phase QMS guidance download Advarra’s whitepaper Steps to Implementing a Quality Management System. A: Working in a pharmaceutical company is the best way to learn this.

Packaging 52

Packaging FDA Trials Regulations 52

The Open Targets Blog

OCTOBER 24, 2023

  A significant challenge for biotech and pharmaceutical companies is to make sense of the signals coming from genome-wide association studies (GWAS), most of which are in the non-coding part of the genome. For larger queries, users should look at OTG’s data download options. 

Bioinformatics 64

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 64

Codon

FEBRUARY 13, 2024

3 Another considerable obstacle to pharmaceutical companies’ interest (and investment) is the fact that for a product to be patentable — and therefore profitable — it has to be considered new and inventive. 4 But the same barriers still exist today. .

Therapies 118

Therapies DNA Virus Clinical Trials 118